Biopharmaceutical leader in the development of treatments for rare diseases
Advise client on implementation of the Patient Protection and Affordable Care Act, specifically with respect  to the creation of a regulatory pathway for biosimilars and provisions dealing with insurance limits (annual/lifetime).
Advise client on legislation related to the 340(b) Drug Pricing Program as it relates to orphan drugs. Monitor legislation related to patent reform.
S. 515 - Patent Reform Act
H.R. 1260 - Patent Reform Act
HCR - Health Issues CPT - Copyright/Patent/Trademark
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX (House Rules Comm Assoc, Subcomm Staff Dir.) DARREN WILLCOX
House Rules Comm Assoc, Subcomm Staff Dir.